Volume | 2,915,874 |
|
|||||
News | (1) | ||||||
Day High | 0.8613 | Low High |
|||||
Day Low | 0.7324 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Assertio Holdings Inc | ASRT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.8613 | 0.7324 | 0.8613 | 0.7851 | 0.8656 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,498 | 2,915,874 | $ 0.7917242 | $ 2,308,568 | - | 0.7324 - 8.01 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:59:30 | formt | 3,600 | $ 0.7998 | USD |
Assertio Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
75.05M | 95.00M | - | 152.07M | -331.94M | -3.49 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Assertio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ASRT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.77 | 0.94 | 0.7324 | 0.8386587 | 847,694 | 0.0298 | 3.87% |
1 Month | 1.01 | 1.02 | 0.7324 | 0.8715413 | 694,051 | -0.2102 | -20.81% |
3 Months | 0.9001 | 1.21 | 0.7324 | 0.9391859 | 939,783 | -0.1003 | -11.14% |
6 Months | 2.24 | 2.37 | 0.7324 | 1.11 | 1,231,604 | -1.44 | -64.29% |
1 Year | 5.24 | 8.01 | 0.7324 | 3.31 | 1,654,012 | -4.44 | -84.74% |
3 Years | 0.56 | 8.01 | 0.419 | 2.98 | 1,431,331 | 0.2398 | 42.82% |
5 Years | 4.27 | 8.01 | 0.33 | 1.70 | 2,329,646 | -3.47 | -81.27% |
Assertio Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain. |